These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23923400)

  • 21. Use of antifungal agents for oral candidiasis: results of a national survey.
    Martínez-Beneyto Y; López-Jornet P; Velandrino-Nicolás A; Jornet-García V
    Int J Dent Hyg; 2010 Feb; 8(1):47-52. PubMed ID: 20096082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed hypersensitivity to oral nystatin.
    Martínez FV; Muñoz Pamplona MP; García EC; Urzaiz AG
    Contact Dermatitis; 2007 Sep; 57(3):200-1. PubMed ID: 17680880
    [No Abstract]   [Full Text] [Related]  

  • 23. Design of novel antifungal mucoadhesive films. Part II. Formulation and in vitro biopharmaceutical evaluation.
    Llabot JM; Palma SD; Manzo RH; Allemandi DA
    Int J Pharm; 2007 May; 336(2):263-8. PubMed ID: 17223291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation design and optimization for the improvement of nystatin-loaded lipid intravenous emulsion.
    Marín-Quintero D; Fernández-Campos F; Calpena-Campmany AC; Montes-López MJ; Clares-Naveros B; Del Pozo-Carrascosa A
    J Pharm Sci; 2013 Nov; 102(11):4015-23. PubMed ID: 23970386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intestinal candidiasis: modern therapeutic tactics].
    Zlatkina AR
    Eksp Klin Gastroenterol; 2005; (6):15-8, 111. PubMed ID: 17378380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacy compounding of medicinal shampoos: an update].
    Varçin M; Vandael A; Zier-Vercammen J
    J Pharm Belg; 2012 Dec; (4):38-48. PubMed ID: 23350210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-administration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible Candida albicans infection in temporarily neutropenic mice.
    Khan MA; Nasti TH; Saima K; Mallick AI; Firoz A; Wajahul H; Ahmad N; Mohammad O
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):249-58. PubMed ID: 15196575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe vulvovaginitis associated with intravaginal nystatin therapy.
    Dan M
    Am J Obstet Gynecol; 2001 Jul; 185(1):254-5. PubMed ID: 11483943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral nystatin as antifungal prophylaxis in critically ill patients: an old SDD tool to be renewed?
    Eggimann P; Wolff M; Garbino J
    Intensive Care Med; 2005 Nov; 31(11):1466-8. PubMed ID: 16195906
    [No Abstract]   [Full Text] [Related]  

  • 30. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
    Sherry Ku M; Li W; Dulin W; Donahue F; Cade D; Benameur H; Hutchison K
    Int J Pharm; 2010 Feb; 386(1-2):30-41. PubMed ID: 19900518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oromucosal film preparations: points to consider for patient centricity and manufacturing processes.
    Krampe R; Visser JC; Frijlink HW; Breitkreutz J; Woerdenbag HJ; Preis M
    Expert Opin Drug Deliv; 2016; 13(4):493-506. PubMed ID: 26559519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and study of lamivudine oral controlled release tablets.
    Ravi PR; Ganga S; Saha RN
    AAPS PharmSciTech; 2007 Dec; 8(4):E101. PubMed ID: 18181522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
    Yi T; Wan J; Xu H; Yang X
    Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of flucytosine 50 mg/mL in extemporaneous oral liquid formulations.
    VandenBussche HL; Johnson CE; Yun J; Patel SA
    Am J Health Syst Pharm; 2002 Oct; 59(19):1853-5. PubMed ID: 12374070
    [No Abstract]   [Full Text] [Related]  

  • 35. Candicidin for vaginal candidiasis.
    Med Lett Drugs Ther; 1972 Nov; 14(23):86-8. PubMed ID: 4567568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extemporaneous compounding of oral liquid dosage formulations and alternative drug delivery methods for anticancer drugs.
    Lam MS
    Pharmacotherapy; 2011 Feb; 31(2):164-92. PubMed ID: 21275495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical inquiries. What is the best treatment for oral thrush in healthy infants?
    Su CW; Gaskie S; Jamieson B; Triezenberg D
    J Fam Pract; 2008 Jul; 57(7):484-5. PubMed ID: 18625176
    [No Abstract]   [Full Text] [Related]  

  • 38. [Case of pulmonary candidiasis treated successfully with nystatin administered orally and in inhalations].
    Banaszkiewicz H; Szklanny L; Formański T
    Wiad Lek; 1978 Apr; 31(8):537-40. PubMed ID: 664685
    [No Abstract]   [Full Text] [Related]  

  • 39. Fungal laryngitis.
    Chandran SK; Lyons KM; Divi V; Geyer M; Sataloff RT
    Ear Nose Throat J; 2009 Aug; 88(8):1026-7. PubMed ID: 19688709
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of gelatine capsules for application of methamphetamine: a new harm reduction approach.
    Mravčík V; Skařupová K; Orlíková B; Zábranský T; Karachaliou K; Schulte B
    Int J Drug Policy; 2011 Mar; 22(2):172-3. PubMed ID: 21242079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.